samedan logo
 
 
 
spacer
home > pmps > autumn 2014 > industry insight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight

Counterfeit drugs are known to exist in both developed and developing countries. However, the true extent of the problem is not really known, since no global study has been carried out. A counterfeit drug is designed to deceive – particularly if it is copied to make it look like the original product – and if it comes from a supposedly legitimate source, purchasers are unlikely to be suspicious.

Martin Dallas at Essentra discusses how anti-counterfeiting and safety legislation – together with technological progress and increasingly demanding consumer requirements – are all contributing to a surge in innovative designs within the pharma packaging sector (page 40). With the new EU Directive on counterfeit medicines set to come into force in 2016, there are significant demands on the industry to both verify authenticity and demonstrate tamper evidence. As pharma has moved towards compact formats for package inserts, this has necessitated major investment in new technology to handle the printing and folding of larger format leaflets, in order to accommodate the level of detail which ever-increasing legislation brings.

Moving away from regulatory demands, other innovations are also playing their part in meeting market requirements. Dallas is confident, however, that with legislative measures and packaging technology driving progress within the pharma sector, it is possible to find the ideal solution to meet the needs of just about any customer – and their consumers.

One approach in particular which addresses the issue of counterfeit medicines is highlighted by Ian Lancaster at the International Hologram Manufacturers Association (page 26). He discusses various solutions – from holograms to packaging integrating QR codes, coding foils and virtual identification. Lancaster concludes that one of the reasons for the success of holograms has been the ability of manufacturers to adapt them and constantly find new applications. He believes that we will see more and more interesting developments for the technology over the coming years, which will undoubtedly offer far-reaching benefits that advance and expand the role of track and trace.

Of course, it is no good having distinctive, unique labelling of products if they are unable to be read and managed by computer systems during storage. This is a concern that is outlined by Rafael Hernández at Honeywell Scanning and Mobility (page 48). Freezing temperatures of -30°C not only affect stored goods, but also all other materials used within the warehouse. Mobile computers, scanners, printers and voice solutions must therefore demonstrate exceptional resistance to the growing use of low-temperature storage.

Hernández reveals how factors such as frost, condensation, and even cold air can have significant deleterious effects on the logistics of storage. He gives five tips on how to achieve the right marriage between printers, devices and labels in the cold store. Seamless tracking and tracing of goods is essential for a smooth and efficient flow within the warehouse – and especially so in frozen storage. The media used play an essential role here, and the most successful solutions can, as ever, be obtained with the competence and experience of a reliable provider.

Cold chain and counterfeiting are just two of the important themes that we have addressed in this issue of PMPS. In addition, we feature topical articles on pre-filled syringes, medical device legislation in Japan, automation and blend uniformity. Finally, make sure you don’t miss either of the interviews from Air France-KLM-Martinair Cargo (page 46) and DHL (page 70).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Analytical Toolbox for Cell and Gene Therapy development

We guide you through the emerging field of gene therapy developments
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement